AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $71,000 | -64.7% | 18,732 | -68.4% | 0.02% | -19.4% |
| Q1 2021 | $201,000 | +390.2% | 59,367 | +262.1% | 0.03% | +342.9% |
| Q3 2020 | $41,000 | -89.6% | 16,396 | -43.4% | 0.01% | -91.0% |
| Q2 2020 | $393,000 | +235.9% | 28,957 | +88.2% | 0.08% | -18.8% |
| Q1 2020 | $117,000 | -52.4% | 15,384 | -65.4% | 0.10% | +74.5% |
| Q4 2018 | $246,000 | +21.8% | 44,507 | +94.1% | 0.06% | +44.7% |
| Q3 2018 | $202,000 | – | 22,925 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |